Literature DB >> 16022692

What's time got to do with it? Inattention to duration in interpretation of survival graphs.

Brian J Zikmund-Fisher1, Angela Fagerlin, Peter A Ubel.   

Abstract

Reports of randomized clinical trials often use survival curves to summarize clinical outcomes over time and graphically demonstrate evidence of treatment effectiveness. Survival curves can also be used in patient communications to display how health risks accumulate over time. In a randomized survey experiment, administered online, we tested whether people viewing survival curves appropriately adjust their risk perceptions to account for the duration shown. Internet users (N= 864) were recruited from a demographically balanced U.S. panel. Participants read about a hypothetical disease and then viewed one of four survival graphs that displayed mortality risks with and without treatment. Survival graphs showed either a visually large or visually small difference between treatments and were labeled to represent either 5-year or 15-year risk statistics. Participants then provided ratings of disease seriousness, as well as treatment effectiveness for each possible treatment. Variations in ratings corresponded more with visual dissimilarity than with changes in the statistical risk exhibited, with participants perceiving somewhat greater disease seriousness and significant differences in treatment effectiveness in large visual difference graphs. We conclude that when people interpret survival curves, they often fail to sufficiently account for the timeframe represented and perceive more risk and larger differences when identical risks are displayed over longer periods of time. We recommend that all presentations of survival graphics, whether to patients, physicians, or scientists, emphasize duration information (e.g., in the title) and remind readers that attending to graph axis labels is the only way to pierce these visual illusions.

Entities:  

Mesh:

Year:  2005        PMID: 16022692     DOI: 10.1111/j.1539-6924.2005.00626.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  13 in total

1.  Perception of Colorectal Cancer Risk does not Enhance Participation in Screening.

Authors:  Keith Dear; Leitha Scott; Sharon Chambers; Mike C Corbett; Doug Taupin
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

2.  Helping patients decide: ten steps to better risk communication.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel
Journal:  J Natl Cancer Inst       Date:  2011-09-19       Impact factor: 13.506

Review 3.  Risky feelings: why a 6% risk of cancer does not always feel like 6%.

Authors:  Brian J Zikmund-Fisher; Angela Fagerlin; Peter A Ubel
Journal:  Patient Educ Couns       Date:  2010-08-23

4.  The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy.

Authors:  Daniel A Hamstra; Skyler B Johnson; Stephanie Daignault; Brian J Zikmund-Fisher; Jeremy M G Taylor; Knoll Larkin; Alexander Wood; Angela Fagerlin
Journal:  Med Decis Making       Date:  2014-10-02       Impact factor: 2.583

Review 5.  Design features of graphs in health risk communication: a systematic review.

Authors:  Jessica S Ancker; Yalini Senathirajah; Rita Kukafka; Justin B Starren
Journal:  J Am Med Inform Assoc       Date:  2006-08-23       Impact factor: 4.497

Review 6.  Clinical implications of numeracy: theory and practice.

Authors:  Wendy Nelson; Valerie F Reyna; Angela Fagerlin; Isaac Lipkus; Ellen Peters
Journal:  Ann Behav Med       Date:  2008-08-02

7.  Effect of different visual presentations on the comprehension of prognostic information: a systematic review.

Authors:  Eman Abukmail; Mina Bakhit; Chris Del Mar; Tammy Hoffmann
Journal:  BMC Med Inform Decis Mak       Date:  2021-08-25       Impact factor: 2.796

8.  How information about the time requirements and legacy effects of treatments influence decision-making in patients with diabetes and hypertension.

Authors:  Neda Laiteerapong; Paige C Fairchild; Aviva G Nathan; Michael T Quinn; Elbert S Huang
Journal:  BMJ Open Diabetes Res Care       Date:  2016-04-27

9.  Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs.

Authors:  Rebecca Dickinson; David K Raynor; Peter Knapp; Jan MacDonald
Journal:  BMJ Open       Date:  2016-12-02       Impact factor: 2.692

Review 10.  Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers.

Authors:  Lyndal J Trevena; Brian J Zikmund-Fisher; Adrian Edwards; Wolfgang Gaissmaier; Mirta Galesic; Paul K J Han; John King; Margaret L Lawson; Suzanne K Linder; Isaac Lipkus; Elissa Ozanne; Ellen Peters; Danielle Timmermans; Steven Woloshin
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.